Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom
NCT01012245
·
clinicaltrials.gov ↗
COMPLETED
Status
28812
Enrollment
INDUSTRY
Sponsor class
Conditions
Glaucoma
Ocular Hypertension
Interventions
OTHER:
no intervention
Sponsor
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.